Projected life-expectancy gains with statin therapy for individuals with elevated c-reactive protein levels
Authors:
- Paul M RidkerPRPaul M Ridker
- Karen M KuntzKKKaren M Kuntz
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- High-Sensitivity C-Reactive ProteinCirculation, 2001
- Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary artery diseaseJACC, 2000
- Low grade inflammation and coronary heart disease: prospective study and updated meta-analysesBMJ, 2000
- C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in WomenNew England Journal of Medicine, 2000
- Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive ProteinCirculation, 1999
- C-Reactive Protein, a Sensitive Marker of Inflammation, Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged MenCirculation, 1999
- Inflammation, Pravastatin, and the Risk of Coronary Events After Myocardial Infarction in Patients With Average Cholesterol LevelsCirculation, 1998
- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenNew England Journal of Medicine, 1997
- Relation of C-Reactive Protein and Coronary Heart Disease in the MRFIT Nested Case-Control StudyAmerican Journal of Epidemiology, 1996